NIKKEI 225
26,945.67 -388.12 (-1.42%) HANG SENG
19,258.76 +258.05 (+1.36%) CRUDE OIL
69.50 +1.86 (+2.75%) GOLD FUTURES
1,943.60 -39.20 (-1.98%) DOW
32,560.60 +316.02 (+0.98%) Bitcoin GBP
23,005.69 -38.67 (-0.17%)
Novozymes A/S (0Q4U.IL)
| Previous close | 341.65 |
| Open | 340.60 |
| Bid | 330.70 x 0 |
| Ask | 347.90 x 0 |
| Day's range | 338.50 - 344.00 |
| 52-week range | 327.30 - 499.00 |
| Volume | |
| Avg. volume | 278,190 |
| Market cap | 91.479B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 25.97 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.00 (1.76%) |
| Ex-dividend date | 03 Mar 2023 |
| 1y target est | N/A |
- Globe Newswire
Invitation to an extraordinary shareholders’ meeting of Novozymes A/S
To the shareholders of NovozymesThe Board of Directors is pleased to invite you to an extraordinary shareholders’ meeting of Novozymes to be held on Thursday March 30, 2023 at 12:00 (noon) CEST at Ballerup Super Arena. Please read the invitation in PDF Til Novozymes’ aktionærerBestyrelsen har hermed fornøjelsen af at invitere til ekstraordinær generalforsamling i Novozymes torsdag den 30. marts 2023 kl. 12.00 i Ballerup Super Arena. Læs venligst den fulde invitation i PDF format Attachments Noti
- Globe Newswire
Invitation to Novozymes' annual shareholders' meeting 2023
To the shareholders of Novozymes A/S The Board of Directors is pleased to invite you to the company's annual shareholders' meeting on Thursday March 2, 2023 at 4:00 pm CET at Ballerup Super Arena Please read the invitation in PDF Til Novozymes A/S' aktionærer Betyrelsen har hermed fornøjelsen af at invitere dig til selskabets ordinære generalforsamling torsdag den 2. marts 2023 kl. 16.00 i Ballerup Super Arena Læs venligst den fulde invitation i PDF format Attachments Invitation to Novozymes' An
- Globe Newswire
Novozymes delivers historically strong full-year results
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, 2026. In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before
